Skip to content

Large-scale study finds link between blood levels of metals and glaucoma.

Glaucoma is the leading cause of irreversible blindness worldwide and a growing public health concern because of an aging global population. It is often associated with increased fluid pressure in the eye.  Glaucoma can permanently damage vision in the affected eye, first by decreasing peripheral vision, and then potentially leading to blindness if left untreated.

Abnormal body levels of essential elements and exposure to toxic trace metals have been postulated to contribute to the pathogenesis of diseases affecting many organ systems, including the eye.  Now, a new study from researchers at University of California, San Francisco, National Yang-Ming University and Stanford University has shown that a lower blood manganese level and higher blood mercury level were associated with greater odds of a glaucoma diagnosis.  The opensource study is published in the journal JAMA Ophthalmology.

The current study investigated the relationship between body levels of 5 trace metals (manganese, mercury, lead, cadmium, and arsenic) and the prevalence of glaucoma which was diagnosed using the ISGEO criteria. Blood or urine metallic element levels and information pertaining to ocular disease were available for 2,680 individuals (19 years and older) participating in the fourth Korea National Health and Nutrition Examination Survey between January 2007 and December 2009.

The data findings showed that lower blood manganese levels and higher blood mercury levels were associated with greater glaucoma prevalence. The results showed no association between blood lead or cadmium levels or urine arsenic levels and a diagnosis of glaucoma.

The researchers surmise that future studies will be necessary to confirm these associations and to explore the role of trace elements in the pathogenesis of glaucoma, as well as possible neuroprotective effects, which could lead to novel therapeutic targets in glaucoma management.

Source:  The JAMA Network

Study finds association between blood levels of trace metals and risk of glaucoma - neuroinnovations

Healthinnovations View All

Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.

Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.

Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio,, the life science, pharmaceutical and healthcare portal.

Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.

Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.

An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.

Leave a Reply

Translate »